IRHYTHM HOLDINGS INC (IRTC)
Health Care · medical devices / digital health · NASDAQ
iRhythm provides AI-powered, wearable ambulatory cardiac monitoring services that streamline the diagnosis of heart arrhythmias for clinicians.
What IRHYTHM HOLDINGS INC does
iRhythm Technologies is a digital healthcare company specializing in ambulatory cardiac monitoring (ACM). The company provides a proprietary, wire-free patch-based biosensor that continuously records ECG data, combined with cloud-based data analytics software to help clinicians detect and diagnose arrhythmias.
Themes: cardiology, wearable health tech, digital diagnostics, AI-enabled healthcare, remote patient monitoring
Fundamentals
- Price$102.60 as of 2026-10-08 close
- Market cap$3.4B as of 2026-07-30 (share count; price 2026-10-08)
- 1-year return-42.7% 2025-10-08 close $179.00 → 2026-10-08 close $102.60
- P/En/a negative earnings
- Net margin-6.0% FY2025, SEC XBRL
- Gross margin+70.6% FY2025, SEC XBRL
- ROE-29.2% FY2025, SEC XBRL
- Debt / equity4.03 as of 2026-09-02
- Revenue growth (YoY)+27.4% as of 2026-09-02
- Revenue CAGR (3y)+22.1% SEC XBRL
- Beta0.76 as of 2026-09-02
- Last reported earnings2026-08-06 SEC EDGAR Form 8-K (Item 2.02)
How IRTC compares in its sector
- net profit marginmiddle range 430 covered Health Care peers, as of 2026-09-02
- operating marginmiddle range 417 covered Health Care peers, as of 2026-09-02
- gross marginmiddle range 189 covered Health Care peers, as of 2026-09-02
- return on equitymiddle range 510 covered Health Care peers, as of 2026-09-02
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How IRHYTHM HOLDINGS INC looks technically
IRHYTHM HOLDINGS INC (IRTC) is trading 20.3% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 150 trading days ago — a "death cross", a bearish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 18, below the 25 that marks a real trend), though sellers have been pushing harder than buyers lately — pressure, not a trend. Momentum is beaten down — its 14-day RSI (a 0–100 momentum gauge) is 30, in oversold territory (below 30). MACD, a trend-momentum gauge, turned bearish about 3 trading days ago (its momentum flipped negative). It just made a new 20-day low, its first since 2026-06-17, breaking below its recent trading range. It is 1.9% above its 52-week low (its lowest price of the past year).
Trend
8
| Distance from the 200-day | it is trading 20.3% below its 200-day average, the long-term trend line — a long-term downtrend | -20.3% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $117.66 | $117.66 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $128.69 | $128.69 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 15 calendar days ago — the swings before that are what the structure reading is measured on | 15 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes above 117.03. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible downward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 150 trading days ago — a "death cross", a bearish long-term signal | 150 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 18, below the 25 that marks a real trend), though sellers have been pushing harder than buyers lately — pressure, not a trend | 17.7 |
Momentum
3
| 14-day RSI | momentum is beaten down — its 14-day RSI (a 0–100 momentum gauge) is 30, in oversold territory (below 30) | 29.9 |
|---|---|---|
| Position in its 14-day range | it is trading near the bottom of its 14-day range ($100.70 to $117.03) — its "stochastic" reading is 12 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 11.6 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 3 trading days ago (its momentum flipped negative) | 3 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $212.00 | $212.00 |
|---|---|---|
| From the 52-week high | it is 51.6% below its 52-week high (its highest price of the past year) | -51.6% |
| Above the 52-week low | it is 1.9% above its 52-week low (its lowest price of the past year) | +1.9% |
| Below the 52-week high | it is 51.6% below its highest point of the past year | 51.6% |
| Since a 20-day breakout | it just made a new 20-day low, its first since 2026-06-17, breaking below its recent trading range | 1 session |
| Since a 55-day breakout | it just made a new 55-day low, its first since 2026-06-17, breaking below its recent trading range | 1 session |
| All-time high | its highest closing price on record is $286.19 (set on 2021-01-27) | $286.19 |
| Given back of the 52-week move | over the past year its closes ranged ($101.79 to $189.25), and it has recovered essentially none of its fall from last year’s high — 1% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $155.84 to $158.64. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 0.9% |
| From the all-time high | it is 64.1% below its all-time high | -64.2% |
| Nearest price level | it is trading 1.3% above a support level at $101.30 — a price it turned at twice since 2026-06-03, most recently on 2026-06-18. Since 2024-10-08 it has 2 such levels below the current price and 14 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -1.3% |
| All-time low | its lowest closing price on record is $22.16 (set on 2016-11-03) | $22.16 |
| Above the all-time low | it is 363.0% above its all-time low | +363.0% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 90% of it) | 10th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $4.29 between its high and its low — about 4.2% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $4.29 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $104.85 and $116.20 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $104.85 – $110.53 – $116.20 |
| Typical daily range (% of price) | its price moves about 4.2% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 4.2% |
| Stretch from the 200-day average | it is trading 6.1 daily ranges below its 200-day average price (20.3% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 6.1 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.30× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a bullish engulfing | 8 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 8 sessions ago |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-10-08 0.6% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and had not traded back through that level by the close | -0.6% |
|---|---|---|
| Gap filled | a 2.7% gap up opened on 2026-08-07 has been "filled" 43 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 43 sessions ago |
Price streaks
1
| Closing streak | it has closed lower 7 sessions in a row, a -10.17% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 7 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 17.1 percentage points (the stock lost 16.1% while the market gained 1.0%) | -17.1% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 22.0 percentage points (the stock lost 18.1% while the market gained 3.8%) | -22.0% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 29.9 percentage points (the stock lost 12.5% while the market gained 17.5%) | -29.9% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 57.7 percentage points (the stock lost 42.7% while the market gained 15.0%) | -57.7% |
Signal agreement
2
| Bullish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bullish state: its RSI momentum gauge is oversold (a beaten-down reading), near the bottom of its 14-day range (oversold) — these describe past price behaviour, not a forecast | 2 of 9 |
|---|---|---|
| Bearish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, a fresh 20-day low, MACD momentum is negative, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 14% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 5.0% of the share price. | -13.6% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 20% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $127.56 — a volume-weighted average of daily closes over 188 sessions, not a true tick-by-tick VWAP. | -19.6% |
|---|---|---|
| Vs the average paid since it last reported | the price is 13% below the average price paid since it last reported on 2026-08-06 (its 10-Q), so the typical buyer over that stretch is under water. That average is $118.14 — a volume-weighted average of daily closes over 45 sessions, not a true tick-by-tick VWAP. | -13.2% |
Price levels it has turned at before
IRTC last closed at $102.60 on 2026-10-08. Since 2024-10-08 it has turned at 2 prices below its last close and 14 above; the 2 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $101.30 | Support | 1.3% below the last close | turned there twice · 2026-06-03 to 2026-06-18 |
| $105.02 | Resistance | 2.4% above the last close | turned there three times · 2025-02-03 to 2026-07-22 |
| $108.69 | Resistance | 5.9% above the last close | turned there three times · 2025-04-02 to 2026-09-21 |
| $92.23 | Support | 10.1% below the last close | turned there three times · 2024-11-06 to 2025-04-07 |
| $112.98 | Resistance | 10.1% above the last close | turned there three times · 2025-01-28 to 2026-04-02 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes above $117.03.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $88.00 and $99.08 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close above $117.03.
This reading has stood for 7 trading days, since 2026-09-30.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Oversold (14-day RSI below 30) · Near the 52-week low · Pulled back from the 12-month high · Broke down to a new 20-day low · MACD just crossed bearish (12/26/9) | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.13 mean, 1=Strong Buy…5=Strong Sell) — 14 analysts
- Mean price target$173.93 range $150.00 – $196.00; median $177.50
Analyst estimates, as of 2026-10-09. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for IRTC
- Consensus EPS estimate$0.04718 next reporting period, as of 2026-10-09
- Estimate change, 30 days+$0.0052 from $0.04198, on 2026-09-04, 35-day window
- Readings revised upward13% of 8 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Dependency on third-party payors and CMS for reimbursement, including potential changes in billing codes or policies.","Cybersecurity incidents, including unauthorized access to sensitive patient and business information, leading to legal and remediation costs.","Intense competition in the cardiac monitoring market and potential intellectual property litigation."]
What changed in the latest 10-Q
AI-assisted comparison of IRTC's 10-Q filed 2026-04-30 against the prior one filed 2025-10-30.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-04-30) specifies the system as 'iRhythm ACM System' rather than 'Zio System'
- Newer filing (2026-04-30) updates patient report milestone from 'over eight million' to 'more than twelve million'
- Newer filing (2026-04-30) updates heartbeat data collection from 'over 2 billion hours' to 'over 3 billion hours'
- Newer filing (2026-04-30) adds 'a tightening labor market' to macroeconomic factors list
- Newer filing (2026-04-30) adds reference to 'Climate-related events, including the increasing frequency of extreme weather events, natural disasters, or other catastrophic events' in macroeconomic discussion
- Newer filing (2026-04-30) adds statement about 'hybrid work arrangements and decision to pursue a sublease' (text appears truncated)
- Removed:
- Older filing (2025-10-30) included nine-month financial comparisons in revenue breakdown table; newer filing (2026-04-30) shows only three-month ended March 31 comparisons
- Older filing (2025-10-30) included nine-month Adjusted EBITDA reconciliation table; newer filing (2026-04-30) shows only three-month ended March 31 reconciliation
- Older filing (2025-10-30) included line items 'Impairment charges' and 'Loss on extinguishment of debt' in Adjusted EBITDA reconciliation; newer filing (2026-04-30) does not show these line items
- Older filing (2025-10-30) included detailed explanation regarding exclusion of patent litigation fees related to Welch Allyn and Bardy Diagnostics; newer filing (2026-04-30) does not include this specific explanation
- Older filing (2025-10-30) references 'commodity price increases' in macroeconomic factors; newer filing (2026-04-30) does not include this phrase
- Older filing (2025-10-30) states 'supply chain disruptions, including shortages'; newer filing (2026-04-30) states 'supply chain disruptions or shortages'
- Reworded:
- Older filing (2025-10-30) references 'Zio Systems' throughout; newer filing (2026-04-30) references 'iRhythm ACM System'
- Older filing (2025-10-30) states revenue comes 'for the iRhythm Services'; newer filing (2026-04-30) states 'for our iRhythm Services'
- Older filing (2025-10-30) defines Adjusted EBITDA exclusions as 'impairment and restructuring charges'; newer filing (2026-04-30) lists only 'impairment charges' in the definition
- Older filing (2025-10-30) macroeconomic factors list includes 'supply chain disruptions, including shortages'; newer filing (2026-04-30) lists 'supply chain disruptions or shortages' as separate items
- Newer filing (2026-04-30) adds clause about 'the impact of any initiatives or programs that we may undertake to address financial and operational challenges faced by our customers' whereas older filing (2025-10-30) includes this phrase in macroeconomic factors section
- Notes:
- Older filing covers nine-month and three-month periods ended September 30; newer filing covers three-month period ended March 31, limiting direct comparability of financial tables
- Text of older filing appears truncated at end of macroeconomic section, preventing complete comparison
- Newer filing text also appears truncated at end of macroeconomic section
Risk Factors
- Added:
- Added phrase '(as defined below)' after 'iRhythm Services' in first Medicare reimbursement bullet point (filed 2026-04-30)
- Added reference to 'orders for' before 'our iRhythm Services' in revenue reliance bullet point (filed 2026-04-30)
- Changed 'Zio Systems' reference to generic 'current products' in medical device regulatory bullet point (filed 2026-04-30)
- Removed 'or approvals' language and simplified to reference 'regulatory certifications' in EU/Japan/Switzerland/UK context (filed 2026-04-30)
- Removed:
- Removed 'sales of' before 'our iRhythm Services' in revenue reliance bullet - changed to 'orders for' (filed 2026-04-30)
- Removed 'additional' before 'material weaknesses' in internal controls bullet point (filed 2026-04-30)
- Removed reference to 'Zio Systems' specifically, replaced with 'current products' (filed 2026-04-30)
- Removed explicit reference to 'medical devices' in the phrase describing FDA clearance context (filed 2026-04-30)
- Reworded:
- Changed 'sales of our iRhythm Services' to 'orders for our iRhythm Services' in revenue reliance bullet (filed 2026-04-30)
- Changed 'Zio Systems are comprised of medical devices' to 'current products are comprised of medical devices' in device authorization bullet (filed 2026-04-30)
- Changed 'regulatory certifications or approvals' to 'regulatory certifications' for EU/Japan/Switzerland/UK references (filed 2026-04-30)
- Changed 'Changes in applicable laws or regulations or the interpretation or enforcement policies of regulators governing our IDTFs and iRhythm Services' to add 'medical devices' category - now reads 'governing our medical devices, IDTFs and iRhythm Services' (filed 2026-04-30)
- Changed 'may identify additional material weaknesses' to 'may identify material weaknesses' - removed 'additional' (filed 2026-04-30)
- Notes:
- Newer filing appears truncated at end of text; comparison limited to complete bullet points visible
- Older filing also appears truncated at end; full text of later risk factors not available for comparison
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 9 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 90 days · read to 2026-10-040 buys · 9 sells ($7M) — 8 selling insiders
- Last 180 days · read to 2026-10-041 buy ($56892) · 19 sells ($9M) — 1 buying, 12 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-09-02. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about IRTC's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding IRTC as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 5,347,128
- Reported value $636,040,837
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 3 increased, 2 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about IRTC's institutional holders → See what each manager we track holds →
Short interest (FINRA)
IRTC had 3,054,907 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
IRTC had 9.27% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 5.56 days to cover at the same settlement.
- Reported short interest (shares) 3,054,907
- Short interest (% of shares outstanding) 9.27%
- Prior settlement (shares) 2,788,408
- Reported change 9.56%
- Days to cover (reported) 5.56
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- BioTelemetry (acquired by Philips)
- AliveCor
- Bardy Diagnostics (acquired by Hillrom/Baxter)
- GE HealthCare (GEHC)
- Medtronic (MDT)
- Boston Scientific (BSX)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare IRTC vs…
Frequently asked questions
What does IRHYTHM HOLDINGS INC (IRTC) do?
iRhythm Technologies is a digital healthcare company specializing in ambulatory cardiac monitoring (ACM). The company provides a proprietary, wire-free patch-based biosensor that continuously records ECG data, combined with cloud-based data analytics software to help clinicians detect and diagnose arrhythmias.
What sector is IRHYTHM HOLDINGS INC (IRTC) in?
IRHYTHM HOLDINGS INC (IRTC) is classified in the Health Care sector. Its industry is medical devices / digital health. It trades on NASDAQ.
Who are IRHYTHM HOLDINGS INC's (IRTC) competitors?
Notable peers of IRHYTHM HOLDINGS INC (IRTC) include BioTelemetry (acquired by Philips), AliveCor, Bardy Diagnostics (acquired by Hillrom/Baxter), GE HealthCare and Medtronic. This peer set is informational only — not financial advice.
Is IRHYTHM HOLDINGS INC (IRTC) overbought or oversold right now?
IRHYTHM HOLDINGS INC (IRTC) is currently in oversold territory (its 14-day RSI is 30, below 30) (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on IRTC come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest; prices are market data, as of 2026-09-02; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.